RPS Advisory Solutions’s AbbVie ABBV Stock Holding History

RPS Advisory Solutions’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$750K	Sell	2,982 -213	-7%	-$45.8K	0.5%	37
2026 Q1	$695K	Buy	3,195 +4	+0.1%	+$887	0.39%	37
2025 Q4	$729K	Buy	3,191 +3	+0.1%	+$683	0.34%	53
2025 Q3	$738K	Buy	3,188 +46	+1%	+$9.37K	0.36%	45
2025 Q2	$583K	Buy	3,142 +77	+3%	+$14.3K	0.32%	48
2025 Q1	$642K	Sell	3,065 -64	-2%	-$12.4K	0.45%	33
2024 Q4	$556K	Sell	3,129 -236	-7%	-$43.4K	0.35%	57
2024 Q3	$664K	Buy	3,365 +4	+0.1%	+$747	0.48%	40
2024 Q2	$576K	Buy	+3,361	New	+$557K	0.53%	43

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

RPS Advisory Solutions's ABBV Position: Q2 2026 in Review

RPS Advisory Solutions reduced its AbbVie (ABBV) stake by 6.7% in Q2 2026, selling an estimated $45.8K and leaving 2,982 shares worth $750K. The position accounts for 0.5% of the portfolio, ranked #37.

RPS Advisory Solutions first reported a position in ABBV in Q2 2024 and has held it in 9 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

RPS Advisory Solutions held 2,982 shares of AbbVie worth $750K as of Q2 2026.
RPS Advisory Solutions sold 213 AbbVie shares in Q2 2026, an estimated $45.8K.
AbbVie made up 0.5% of RPS Advisory Solutions's portfolio in Q2 2026, its #37 holding.
RPS Advisory Solutions first reported a position in AbbVie in Q2 2024 and has held it in 9 quarters since.
4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on RPS Advisory Solutions's 13F filing for Q2 2026, filed 11 Aug 2026.